Assay kits are used to carry out analyses in a broad scope of applications including the study of targets such as drugs, molecules, disease pathways, chemical elements or compounds, and organisms. They are a routine procedure in the modern pharmaceutical, medical and forensic world as well as research and university laboratories around the globe. Assay kits come with all the necessary reagents, instructions and protocols for fast and efficient processing, allowing for repeatable results.
|  | | | | |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | HE4 ELISA Assay | ANGPTL4 ELISA Assay | Anti-Tocilizumab (Actemra®) ELISA | C4a Des Arg RIA Assay | S100B ELISA Assay |
| Citations | | | | | |
| Catalog Number | 404-10US | 27749 | TM09021 | RK-519 | 708-85 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | The HE4 EIA is an enzyme immunometric assay for the quantitative determination of HE4 in human serum. The assay is to be used as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer. Serial testing for patient HE4 assay values should be used in The HE4 EIA is an enzyme immunometric assay for the quantitative determination of HE4 in human serum. The assay is to be used as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer. Serial testing for patient HE4 assay values should be used in conjunction with other clinical methods used for monitoring ovarian cancer.... Read More | Solid phase sandwich ELISA for the determination of human ANGPTL4 in serum and EDTA-plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Tocilizumab (Actemra®) in serum and plasma. For research use only, not for use in diagnostic procedures. | Radioimmunoassay (RIA) for the determination of human Complement C4a des Arg in human plasma. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) for the determination of S100B (S100A1B + S100BB) in serum. For research use only, not for use in diagnostic procedures. |
| Detection Target | Alpha2,6-Sialyltransferase (Alpha2,6-ST) | C5a | S100B | Leishmania infantum IgG | Complement System Alternative Pathway |
| Sample Type | Serum, Blood Plasma, Cell Culture Supernatant | Blood Plasma, Urine | Serum | Serum, Blood Plasma | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 15 to 900 pM | 23.44 to 1500 pg/mL | 0 / 6 to 200 ng/mL | 40 to 1300 ng/mL | 10 to 3500 ng/L |
| Sensitivity | 0.20 ng/mL | < 0.02 µg/L | Inquire | 0.91 | Inquire |
| Assay Time | 2 hrs 30 mins (incubation) | 2 hrs (incubation) | 2 hours, 10 min. total incubation time. | 1 hr, 30 mins (incubation) | 3 hrs 30 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |